The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype
Open accessAbstract
CD163 is a member of the scavenger receptor cysteine-rich superfamily restricted to the monocyte/macrophage lineage and is thought to be a useful marker for anti-inflammatory or alternatively activated macrophages. In this study we used mass spectrometric analysis to determine that the antigen recognized by the antibody AM-3K, which we previously generated as a tissue macrophage-specific monoclonal antibody, was CD163. An anti-inflammatory subtype of macrophages stimulated by dexamethasone or interleukin-10 showed strong reactivity for AM-3K and increased expression of CD163 mRNA. Immunohistochemical staining of routinely processed pathological specimens revealed that AM-3K recognized a specialized subpopulation of macrophages. In granulomatous diseases such as tuberculosis, sarcoidosis, or foreign body reactions, tissue macrophages around granulomas, but not component cells of the granulomas such as epithelioid cells and multinucleated giant cells, showed positive staining for AM-3K. In atherosclerotic lesions, scattered macrophages in diffuse intimal lesions were strongly positive for AM-3K, whereas foamy macrophages in atheromatous plaques demonstrated only weak staining. We therefore suggest that, in routine pathological specimens, AM-3K is a useful marker for anti-inflammatory macrophages because these cells can be distinguished from inflammatory or classically activated macrophages. Because AM-3K cross-reacts with macrophage subpopulations in different animal species including rats, guinea pigs, rabbits, cats, dogs, goats, pigs, bovine species, horses, monkeys, and cetaceans, it will have wide application for detection of CD163 in various animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
The many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902 · cited 1×
“…expressed by alternatively activated macrophages, whereas tumor necrosis factor-a (TNF-a), IL-1b, IL-6, IL-12, and inducible nitric oxide synthase (iNOS) showed restricted expression by these macrophages (Goerdt and Orfanos 1999; Gordon 2003; Mosser 2003; Mantovani et al. 2004; Taylor et al. 2005).”
BackgroundBer-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.
Backé, E., Schwarting, R., Gerdes, J., Ernst, M., & Stein, H. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.11.936 · Cited by 92 · cited 2×
“…lesions macrophage markers CD163 CD163 is a monocyte/macrophage-restricted membrane protein belonging to the scavenger receptor cysteine-rich (SRCR) domain family (Backé et al. 1991; Pulford et al. 1992; Law et al. 1993;Högger et al. 1998a; Buechler et al. 2000; Lau et al. 2004).”
Background
Cited by
Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
Self-citationClinical significance of macrophage heterogeneity in human malignant tumors
Komohara, Y., Jinushi, M., & Takeya, M. (2014) · Cancer Science · doi:10.1111/cas.12314 · Cited by 551
Self-citationThe endometrial immune environment of women with endometriosis
Vallvé-Juanico, J., Houshdaran, S., & Giudice, L. C. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz018 · Cited by 524
Burkard, C., Lillico, S. G., Reid, E., Jackson, B., Mileham, A. J., Ait-Ali, T., Whitelaw, C. B. A., & Archibald, A. L. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006206 · Cited by 378
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
Van Gorp, H., Delputte, P. L., & Nauwynck, H. J. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.008 · Cited by 357
Mano, Y., Shirabe, K., Yamashita, Y.-I., Harimoto, N., Tsujita, E., Takeishi, K., Aishima, S., Ikegami, T., Yoshizumi, T., Yamanaka, T., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e318297ad6b · Cited by 311
Jensen, T. O., Schmidt, H., Møller, H. J., Høyer, M., Maniecki, M. B., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9919 · Cited by 299
Chen, X., Zhou, J., Li, X., Wang, X., Lin, Y., & Wang, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.001 · Cited by 287
Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
Komohara, Y., Hasita, H., Ohnishi, K., Fujiwara, Y., Suzu, S., Eto, M., & Takeya, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01945.x · Cited by 264
Self-citationSoluble Macrophage Biomarkers Indicate Inflammatory Phenotypes in Patients With Knee Osteoarthritis
Daghestani, H. N., Pieper, C. F., & Kraus, V. B. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39006 · Cited by 258
Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation
Shiraishi, D., Fujiwara, Y., Komohara, Y., Mizuta, H., & Takeya, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.086 · Cited by 208
Self-citationMacrophage heterogeneity in atherosclerotic plaques
Johnson, J. L., & Newby, A. C. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283309848 · Cited by 183
Wolfs, I., Donners, M., & de Winther, M. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0320 · Cited by 157
Multiple sclerosis and Alzheimer's disease
Dal Bianco, A., Bradl, M., Frischer, J., Kutzelnigg, A., Jellinger, K., & Lassmann, H. (2008) · Annals of Neurology · doi:10.1002/ana.21240 · Cited by 123
Lesional Accumulation of CD163+ Macrophages/microglia in Rat Traumatic Brain Injury
Zhang, Z., Zhang, Z.-Y., Wu, Y., & Schluesener, H. J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.038 · Cited by 83
Fu, H., Alabdullah, M., Großmann, J., Spieler, F., Abdosh, R., Lutz, V., Kalies, K., Knöpp, K., Rieckmann, M., Koch, S., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2109-9 · Cited by 51
Li, S., Wu, Y., Jiang, G., Tian, X., Hong, J., Chen, S., Yan, R., Feng, G., & Cheng, Z. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3006 · Cited by 20
Metadata
- Authors
- Komohara, Y., Hirahara, J., Horikawa, T., Kawamura, K., Kiyota, E., Sakashita, N., Araki, N., & Takeya, M.
- Venue
- Journal of Histochemistry & Cytochemistry
- Publisher
- SAGE Publications
- Published
- 2006-07
- Volume
- 54
- Issue
- 7
- Pages
- 763-771
- ISSN
- 0022-1554 (ISSN-L)
- 1551-5044
- OpenAlex
- W2138420245
- Cited by
- 172
- References
- 4
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.